CatalystPit

SRZNSurrozen, Inc./DE

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $32.18 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$378.23M
CountryUSA
RECENT INSIDER TRADES
  • 2026-07-24 · TCG Crossover GP II, LLC (10% Owner) · SELL
  • 2026-06-16 · Williams Charles O (Chief Operating Officer) · OTHER
  • 2026-06-16 · Li Yang (Exec. Vice President, Research) · OTHER
  • 2026-06-16 · Parker Craig C (Chief Executive Officer) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders71
Shares held10,756,952
Value$271.32M
Percent of shares outstanding91.52%
As of quarter end2026-06-30
RECENT NEWS
  • Surrozen wins FDA approval
  • H.C. Wainwright raises Surrozen price target on Wnt pathway validation
  • Surrozen presents at Morgan Stanley Global Healthcare Conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Surrozen, Inc./DE (SRZN) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit